KNO yields 1.09% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, KNO + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KNO + MRK for your $10,000?
KNO is actively managed to invest in a portfolio of large- and midcap companies perceived to be innovative potentially capturing outperformance through a knowledge effect. The fund will invest in developed market countries excluding Hong Kong, non-US stocks will have at least 40% exposure to these markets. KNOs proprietary model adjusts historical financial statements for intangibles and capitalizes a companys financial strength, profitability, and investment in innovation. After these adjustments, the fund adviser selects the most liquid companies. Intangible assets include R&D, advertising, brand development, and employee training expenses. Prior to May 26, 2020, the fund tracked the Knowledge Leaders Developed World Index. Also, Knowledge Leaders Capital, LLC replaced Exchange Traded Concepts, LLC as its investment adviser. On July 22, 2023, the ETF acquired all assets and liabilities of the Knowledge Leaders Developed World ETF (KLDW), which had about $130 million in assets.
Full KNO Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.